Arbital Health is excited to announce a major milestone in our journey to transform value-based care. We have successfully raised $31,000,000 in our latest funding round, positioning us to accelerate our mission to revolutionize the adjudication and management of care contracts. This significant capital infusion will empower us to scale our actuarial science-powered platform, which centralizes, measures, and adjudicates contracts with the transparency and precision essential for success in today’s healthcare landscape. By incorporating advanced data-driven tools and actuarial advisory services, Arbital Health ensures that our partners can achieve greater financial stability while enhancing the quality of care across the board.
Our fresh yet robust startup, backed by a founding team with over fifteen years of experience and multiple successful exits in the healthcare industry, is poised to tackle one of the most critical challenges facing the US healthcare system today—incentive alignment. The funds will be strategically invested in further refining our neutral, third-party adjudication utility, which is designed to bolster outcomes-based healthcare contracts. We believe that by addressing these strategic gaps, Arbital Health is not just advancing its own innovations but also contributing to the broader industry transition toward value-based care—a shift estimated to be worth over $1 trillion.
This investment marks a significant step in our commitment to redefining contract management within healthcare, enabling more precise risk management and improved patient outcomes. As we continue to scale our offerings and reach new heights, we look forward to driving impactful change and making quality healthcare more accessible and financially sustainable for all stakeholders.
